Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2026)
Volitionrx's (VNRX) quarterly Total Non-Current Liabilities came in at $31.0 million in Q3 2025, up 514.48% YoY from $5.0 million in Q3 2024, and down 4.87% on a QoQ basis from $32.6 million in Q2 2025.
Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Volitionrx (VNRX) has 8 years of Total Non-Current Liabilities data on file, last reported at $31.0 million in Q3 2025.
- Quarterly Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $31.0 million (up 514.48% YoY) and the FY2024 annual result came in at $27.7 million, up 474.36% from the prior year.
- Total Non-Current Liabilities slipped to $31.0 million in Q3 2025, from $32.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $32.6 million in Q2 2025 to a low of $3.2 million in Q3 2023.
- A 5-year average of $13.9 million and a median of $8.7 million in 2021 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities sank 58.45% — and 2025, when it surged 552.55%.
- Tracing VNRX's Total Non-Current Liabilities over 5 years: stood at $9.7 million in 2021, then slumped by 58.45% to $4.0 million in 2022, then rose by 19.57% to $4.8 million in 2023, then soared by 474.36% to $27.7 million in 2024, then increased by 11.76% to $31.0 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $31.0 million (Q3 2025), $32.6 million (Q2 2025), and $29.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | 28.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.35 Mn |
| Dec 31, 2025 | 30.26 Mn |
| Sep 30, 2025 | 30.98 Mn |
| Jun 30, 2025 | 32.56 Mn |
| Mar 31, 2025 | 29.27 Mn |
| Dec 31, 2024 | 27.72 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Dec 31, 2022 | 4.04 Mn |
| Mar 31, 2022 | 20.82 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | 8.77 Mn |
| Jun 30, 2021 | 8.56 Mn |
| Dec 31, 2020 | 9.80 Mn |
| Sep 30, 2019 | 2.73 Mn |
| Dec 31, 2018 | 3.02 Mn |